.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
QuintilesIMS
Julphar
Colorcon
Fuji
Cipla
Daiichi Sankyo
UBS
Novartis
Chinese Patent Office

Generated: December 12, 2017

DrugPatentWatch Database Preview

Medimetriks Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for MEDIMETRIKS PHARMS, and what generic and branded alternatives to MEDIMETRIKS PHARMS drugs are available?

MEDIMETRIKS PHARMS has eight approved drugs.



Summary for Medimetriks Pharms

US Patents:0
Tradenames:5
Ingredients:4
NDAs:8
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Medimetriks PharmsSYNALAR-HPfluocinolone acetonideCREAM;TOPICAL016161-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsNEO-SYNALARfluocinolone acetonide; neomycin sulfateCREAM;TOPICAL060700-001Approved Prior to Jan 1, 1982RXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsSYNALARfluocinolone acetonideSOLUTION;TOPICAL015296-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsSYNALARfluocinolone acetonideCREAM;TOPICAL012787-004Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsLOPROXciclopiroxCREAM;TOPICAL018748-001Dec 30, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsSYNALARfluocinolone acetonideCREAM;TOPICAL012787-002Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsBETAXOLOL HYDROCHLORIDEbetaxolol hydrochlorideSOLUTION/DROPS;OPHTHALMIC075630-001Apr 12, 2001ATRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsSYNALARfluocinolone acetonideOINTMENT;TOPICAL013960-001Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsSYNALARfluocinolone acetonideCREAM;TOPICAL012787-005Approved Prior to Jan 1, 1982ATRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Medimetriks PharmsLOPROXciclopiroxSUSPENSION;TOPICAL019824-001Dec 30, 1988ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Medimetriks Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medimetriks PharmsLOPROXciclopiroxCREAM;TOPICAL018748-001Dec 30, 1982► Subscribe► Subscribe
Medimetriks PharmsLOPROXciclopiroxSUSPENSION;TOPICAL019824-001Dec 30, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MEDIMETRIKS PHARMS drugs

Drugname Dosage Strength Tradename Submissiondate
ciclopiroxGel0.77%LOPROX5/10/2006

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
Moodys
Medtronic
Argus Health
Baxter
UBS
Teva
Federal Trade Commission
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot